To explore the relationship between adherence to anti-tuberculous therapy and mortality risk in patients with tuberculous arthritis, highlighting its significance for patient outcomes.
Key Findings:
391 patients diagnosed with tuberculous arthritis were enrolled.
87 patients died during the follow-up period, while 304 survived.
Deceased patients had a significantly higher mean age (71.1 years) compared to survivors (64.41 years), indicating age as a critical factor.
Interpretation:
Adherence to anti-tuberculous therapy is crucial for improving survival rates in patients with tuberculous arthritis, with age being a significant factor in mortality risk, emphasizing the need for adherence to prevent complications.
Limitations:
Retrospective design may introduce bias, and limited data on other potential confounding factors affecting mortality.
Conclusion:
Improving adherence to anti-tuberculous therapy could enhance survival outcomes in patients with tuberculous arthritis, suggesting targeted interventions to support adherence.
